news_head_banner

Newsroom

  • Zeesan team has recently concluded a remarkable visit to MEDLAB

    Zeesan team has recently concluded a remarkable visit to MEDLAB

    The Zeesan team has just returned from a highly successful trip to MEDLAB Middle East 2024. During this incredible event, our team had the opportunity to meet existing clients, establish new connections, and foster collaborations with potential partners. We were delighted to share our innovative ...
    Read more
  • See you soon at MEDLAB Middle East 2024!

    See you soon at MEDLAB Middle East 2024!

    We are excited to meet you again at MEDLAB Middle East on 5-8 Feb, 2024. Venue: Dubai World Trade Centre, Dubai, UAE Booth No.: Z2.A59 See you soon!  
    Read more
  • Merry Christmas!

    Merry Christmas!

    We want to extend a special thank you to our incredible clients and business partners. Your unwavering support has fueled our efforts to innovate and find new solutions to the unique challenges we have faced in the past year. We would like to wish you and your loved ones a joyful Merry Christmas ...
    Read more
  • Zeesan team showcases Sanity 2.0 System at MEDICA

    Zeesan team showcases Sanity 2.0 System at MEDICA

    This past week at MEDICA 2023 was nothing short of inspirational for us. We had the profound opportunity to engage with health professionals from around the globe, each converging in one space with a shared mission – advancing healthcare. The diversity of expertise and insights on offer mad...
    Read more
  • Welcome to our booth 17A02-3 at MEDICA 2023

    Welcome to our booth 17A02-3 at MEDICA 2023

    We are excited to announce that our team will be participating in MEDICA 2023. At this prestigious gathering of medical professionals, we look forward to showcasing our innovative solutions - Sanity 2.0 System, designed for the detection of respiratory pathogens, HPV, TB...
    Read more
  • SCIENCE BLOG | How much do you know about leukemia?

    SCIENCE BLOG | How much do you know about leukemia?

    Leukemia, also known as blood cancer, is a kind of clonal malignant disease with abnormal hematopoietic stem cells (HSC). The pre-leukemic HSC clones lose the ability to further differentiate and mature, thus stagnate at different stag...
    Read more
  • Visit us at 2023 AACC Clinical Lab Expo

    Visit us at 2023 AACC Clinical Lab Expo

    We will be having a booth at 2023 AACC Clinical Lab Expo. Expo Dates: July 25-27, 2023 Venue:  Anaheim Convention Center, Anaheim, California, United States Booth No.: 3071  (Hall B) Come to visit us. We look forward to seeing you!
    Read more
  • International HPV Awareness Day, A Concerted Effort to End HPV

    March 4, 2023 is the sixth “HPV Awareness Day”, which was initiated by the International Papillomavirus Society (IPVS) to raise awareness of HPV prevention and control, call for public attention and understanding of the human papillomavirus (HPV) and its dangers, and eli...
    Read more
  • [GOOD NEWS] ZEESAN’s MDR-TB Test Kit (MMCA) was listed for priority approval of medical devices in NMPA

    On March 20, the Center for Medical Device Evaluation, National Medical Products Administration (NMPA, China) publicized the list of IVD products that are obtained the priority approval of medical devices. MDR-TB Test Kit(Cat. No.: 801213) from Zeesan Biotech was passed ...
    Read more
  • ZEESAN showcases its total solution to molecular diagnositics at Medlab Middle East 2023

    ZEESAN brought its total solution to molecular diagnostics and its fully automated system to participate in the Medlab Middle East 2023 in Dubai, UAE, from February 6-9, 2023. Medlab Middle East is the largest laboratory equipment exhi...
    Read more
  • Scaling up diagnosis to end TB epidemic – ” Global Plan to End TB, 2023-2030″, ZEESAN in action

    The Stop TB Partnership, an organization managed by the United Nations Office for Project Services (UNOPS), released the “Global Plan to End TB, 2023-2030″ (hereinafter “Global Plan”) on August 16, 2022. The Global Plan to end TB, a major public health challenge, by 2030...
    Read more

Interested to Know More about Our Solution to Molecular Diagnostics?

Let’s talk